题目内容
（请给出正确答案）
A、came down to
B、found out
C、took advantage of
D、took over
如果结果不匹配，请 联系老师 获取答案
更多“Carl ___________ the duties an…”相关的问题
A.imagine
B.notice
C.examine
D.review
Wang Hong is working in the same lab ______ her friend Carl Cooper
A.for
B.with
C.within
D.to
A.Carl Deckard
B.Chuck Hull
C.Scott Crump
D.Michael Feygi
A.Scott Crump
B.Chuck Hull
C.Michael Feygin
D.Carl Deckard
A.Carl Lewis
B.Michael Johnson
C.Steve prefontaine
D.Steve Ovett
B.足球运动员
C.鲜美的菜肴
D.估计理论中的著名定理，来自于著名的统计学家：Johann Carl FriedrichG auss和Andrey Andreevich Markov。
A.英国人汉考克（Hancock）
B.美国人查尔斯.固特异（Charles Goodyear）
C.德国人卡尔.齐格勒（Carl Ziegler）
D.意大利人久里奥.纳塔（Giulio Natta）
It' s not entirely clear why medicine has been so slow to build on Anderson's early success. The National Institutes of Health budget office estimates it will spend $ 432 million on gene-therapy research in 2005, and there is no shortage of promising leads. The therapeutic genes are usually delivered through viruses that don't cause human disease. "The virus is sort of like a Trojan horse, " says Ronald Crystal of New York Presbyterian/Weill Cornell Medical College. "The cargo is the gene. "
At the University of Pennsylvania's Abramsoh Cancer Center, immunologist Carl June recently treated HIV patients with a gene intended to help their cells resist the infection. At Cornell University, researchers are pursuing gene-based therapies for Parkinson' s disease and a rare hereditary disorder that destroys children' s brain cells. At Stanford University and the Children' s Hospital of Philadelphia, researchers are trying to figure out how to help patients with hemophilia who today must inject themselves with expensive clotting drugs for life. Animal experiments have shown great promise.
But somehow, things get lost in the translation from laboratory to patient. In human trials of the hemophilia treatment, patients show a response at first, but it fades over time. And the field has still not recovered from the setback it suffered in 1999, when Jesse Gelsinger, an 18-year-old with a rare metabolic disorder, died after receiving an experimental gene therapy at the University of Pennsylvania. Some experts worry that the field will be tarnished further if the next people to benefit are not patients but athletes seeking an edge. This summer, researchers at the Salk Institute in San Diego said they had created a "marathon mouse" by implanting a gene that enhances running ability; already, officials at the World Anti-Doping Agency are preparing to test athletes for signs of "gene doping". But the principle is the same, whether you' re trying to help a healthy runner run faster or allow a muscular-dystrophy patient to walk. "Everybody recognizes that gene therapy is a very good idea, " says Crystal. "And eventually it's going to work. "
The case of Ashanthi Desilva is mentioned in the text to______.
A．show the promise of gene-therapy
B．give an example of modern treatment for fatal diseases
C．introduce the achievement of Anderson and his team
D．explain how gene-based treatment works
